Oaktree Acquisition Corp. III Life Sciences Warrant (OACCW) is a special purpose acquisition company (SPAC) dedicated to merging with high-growth enterprises within the life sciences sector. Backed by the significant resources and industry acumen of Oaktree Capital Management, a prominent player in global investment management, OACCW seeks to harness its extensive networks to drive innovation and create value in healthcare investments. This warrants present an attractive opportunity for investors to gain exposure to the rapidly expanding life sciences market, capitalizing on the strategic advantages afforded by Oaktree's expertise and operational support.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.37M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |